74 related articles for article (PubMed ID: 22874743)
1. Anaphylaxis with tissue plasminogen activator: case report and literature review.
Patel M; Rumore MM
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):568-70. PubMed ID: 22874743
[No Abstract] [Full Text] [Related]
2. Invited commentary.
Henke PK
J Vasc Surg; 2010 Nov; 52(5):1270-1. PubMed ID: 21050988
[No Abstract] [Full Text] [Related]
3. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
[TBL] [Abstract][Full Text] [Related]
4. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
[No Abstract] [Full Text] [Related]
5. Anaphylactoid reaction to recombinant tissue plasminogen activator.
Krmpotic KR; Fernandes CM
Eur J Emerg Med; 2007 Feb; 14(1):60-1. PubMed ID: 17198333
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial thrombolysis in patients treated with warfarin.
Linfante I; Reddy AS; Andreone V; Caplan LR; Selim M; Hirsch JA
Cerebrovasc Dis; 2005; 19(2):133-5. PubMed ID: 15637435
[No Abstract] [Full Text] [Related]
7. Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics.
Newall F; Browne M; Savoia H; Campbell J; Barnes C; Monagle P
J Pediatr Hematol Oncol; 2007 Apr; 29(4):269-73. PubMed ID: 17414572
[TBL] [Abstract][Full Text] [Related]
8. Successful delayed thrombolysis for cerebral venous and dural sinus thrombosis: a case report and review of the literature.
Hocker SE; Dafer RM; Hacein-Bey L
J Stroke Cerebrovasc Dis; 2008; 17(6):429-32. PubMed ID: 18984441
[TBL] [Abstract][Full Text] [Related]
9. [Waran following thrombolysis with Actilyse].
Ohlsson S; Böttiger Y
Lakartidningen; 2006 Mar 15-21; 103(11):853. PubMed ID: 16613115
[No Abstract] [Full Text] [Related]
10. Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator.
Wang CT; Lin FC; Khor GT; Chen CH; Huang P
Am J Emerg Med; 2012 Jan; 30(1):253.e1-2. PubMed ID: 21109385
[TBL] [Abstract][Full Text] [Related]
11. Intravenous tissue plasminogen activator thrombolysis in patients without major arterial occlusion seems to be safe and effective.
Kimura K; Iguchi Y; Shibazaki K; Sakamoto Y; Watanabe M
Eur Neurol; 2010; 64(5):258-64. PubMed ID: 20948218
[TBL] [Abstract][Full Text] [Related]
12. Intraventricular tissue plasminogen activator toxicity.
Gaberel T; Emery E
Neurosurgery; 2011 Jan; 68(1):E288-9; author reply E289. PubMed ID: 21150745
[No Abstract] [Full Text] [Related]
13. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Pfeilschifter W; Bohmann F; Baumgarten P; Mittelbronn M; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C
Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
[TBL] [Abstract][Full Text] [Related]
14. Clinical pearls in thrombosis and anticoagulation.
Merli GJ; Litin SC
Mayo Clin Proc; 2009 Dec; 84(12):1120-4. PubMed ID: 19955248
[No Abstract] [Full Text] [Related]
15. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
Marder VJ
Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the optimal timing of angiography: landmark or off the mark?
Normand SL
Circulation; 2007 Dec; 116(23):2656-7. PubMed ID: 18056535
[No Abstract] [Full Text] [Related]
17. Hypersensitivity reactions associated with recombinant tissue-type plasminogen activator and urokinase.
Pechlaner C; Knapp E; Wiedermann CJ
Blood Coagul Fibrinolysis; 2001 Sep; 12(6):491-4. PubMed ID: 11555703
[TBL] [Abstract][Full Text] [Related]
18. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients.
Kim HS; Preece SR; Black JH; Pham LD; Streiff MB
J Vasc Surg; 2008 Feb; 47(2):388-94. PubMed ID: 18241762
[TBL] [Abstract][Full Text] [Related]
19. Reactions to alteplase in patients with acute thrombotic stroke.
Chodirker WB
CMAJ; 2000 Aug; 163(4):387-9. PubMed ID: 10976251
[No Abstract] [Full Text] [Related]
20. Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.
Crowther MA; Roberts J; Roberts R; Johnston M; Stevens P; Skingley P; Patrassi GM; Sartori MT; Hirsh J; Prandoni P; Weitz JI; Gent M; Ginsberg JS
Thromb Haemost; 2001 Mar; 85(3):390-4. PubMed ID: 11307802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
